PubMed

Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team.

Diabetes Care. 2006 Jan;29(1):1-8.PMID: 16373887 [PubMed - indexed for MEDLINE]Related articlesFree article

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study).

Kennedy L, Herman WH; GOAL A1C Study Team.

Diabetes Technol Ther. 2005 Dec;7(6):907-12.PMID: 16386096 [PubMed - indexed for MEDLINE]Related articles

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.

Riddle M, Frias J, Zhang B, Maier H, Brown C, Lutz K, Kolterman O.

Diabetes Care. 2007 Nov;30(11):2794-9. Epub 2007 Aug 13.PMID: 17698615 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.

Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S.

JAMA. 1997 Nov 26;278(20):1663-9. Erratum in: JAMA 1999 Jun 2;281(21):1989. PMID: 9388085 [PubMed - indexed for MEDLINE]Related articles

Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.

Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R; ATLANTUS Study Group.

Diabetes Care. 2005 Jun;28(6):1282-8.PMID: 15920040 [PubMed - indexed for MEDLINE]Related articlesFree article

DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes.

Buse JB, Wolffenbuttel BH, Herman WH, Shemonsky NK, Jiang HH, Fahrbach JL, Scism-Bacon JL, Martin SA.

Diabetes Care. 2009 Jun;32(6):1007-13. Epub 2009 Mar 31.PMID: 19336625 [PubMed - indexed for MEDLINE]Related articlesFree article

Dosing of insulin glargine in the treatment of type 2 diabetes.

Barnett A.

Clin Ther. 2007 Jun;29(6):987-99. Review.PMID: 17692716 [PubMed - indexed for MEDLINE]Related articles

A prospective, randomized, multicentered controlled trial to compare the annual outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: a 3-month interim analysis.

Lindsey CC, Carter AW, Mangum S, Greene D, Richardson A, Brown S, McCandless B.

Diabetes Technol Ther. 2002;4(5):637-42.PMID: 12450445 [PubMed - indexed for MEDLINE]Related articles

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH; Lispro Mixture-Glargine Study Group.

Clin Ther. 2004 Dec;26(12):2034-44. Erratum in: Clin Ther. 2005 Jul;27(7):1112. PMID: 15823767 [PubMed - indexed for MEDLINE]Related articles

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

Self-monitoring of blood glucose with finger tip versus alternative site sampling: effect on glycemic control in insulin-using patients with type 2 diabetes.

Knapp PE, Showers KM, Phipps JC, Speckman JL, Sternthal E, Freund KM, Ash AS, Apovian CM.

Diabetes Technol Ther. 2009 Apr;11(4):219-25.PMID: 19344196 [PubMed - indexed for MEDLINE]Related articles

Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.

Harris S, Yale JF, Dempsey E, Gerstein H.

Can Fam Physician. 2008 Apr;54(4):550-8.PMID: 18411384 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy.

Zick R, Petersen B, Richter M, Haug C; SAFIR Study Group.

Diabetes Technol Ther. 2007 Dec;9(6):483-92.PMID: 18034602 [PubMed - indexed for MEDLINE]Related articles